Enhanced oxidative stress in Hashimoto's thyroiditis: Inter-relationships to biomarkers of thyroid function

Clinical Biochemistry

Volumn 46, Issue 4-5, 2013, Pages 308-312

  Rostami, R ^a   Aghasi, M R ^a   Mohammadi, A ^a   Nourooz Zadeh, J ^a  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cellular antioxidants; Glutathione; Hashimato's thyroiditis; Iodine; Oxidative stress

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY;

ADULT; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME ACTIVITY; FEMALE; HASHIMOTO DISEASE; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; THYROID FUNCTION;

ADULT; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HASHIMOTO DISEASE; HUMANS; IODIDE PEROXIDASE; IODINE; IRON-BINDING PROTEINS; OXIDATIVE STRESS; THYROID GLAND; THYROTROPIN; YOUNG ADULT;

EID: 84873708974     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.11.021     Document Type: Article

References (51)

1. Scofield R.H. Autoantibodies as predictors of disease. Lancet 2004, 364(9420):1544-1546.
2. Kurien B.T., Scofield R.H. Free radical mediated peroxidative damage in systemic lupus erythematosus. Life Sci 2003, 73(13):1655-1666.
3. Jaswal S., Mehta H.C., Sood A.K., Kaur J. Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clin Chim Acta 2003, 338(1-2):123-129.
4. Kurien B.T., Scofield R.H. Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev 2008, 7(7):567-573.
5. Rose N.R., Bonitab R., Bureka C.L. Iodine: an environmental trigger of thyroiditis. Autoimmun Rev 2002, 1(1-2):97-103.
6. Burek C.L., Rose N.R. Autoimmune thyroiditis and ROS. Autoimmun Rev 2008, 7(7):530-537.
7. Fountoulakis S., Tsatsoulis A. On the pathogenesis of autoimmune thyroid disease: a unifying hypothesis. Clin Endocrinol 2004, 60(4):397-409.
8. Teng W., Shan Z., Teng X., Guan H., Li Y., Teng D., et al. Effect of iodine intake on thyroid diseases in China. N Engl J Med 2006, 354(26):2783-2793.
9. Konno N., Yuri K., Taguchi H., Miura K., Taghuchi S., Hagiwara K., et al. Screening for thyroid diseases in an iodine sufficient area with sensitive thyrotrophin assay, and serum thyroid antibody and urinary iodide determination. Clin Endocrinol 1993, 38(3):273-281.
10. Shan Z.Y., Li Y.S., Wang Z.Y., Jin Y., Guan H.X., Hu F.N., et al. Effect of different iodine intake on the prevalence of hypothyroidism in 3 counties in China. Chin Med J (Engl) 2005, 118(22):1918-1920.
11. Silva J.E. Effects of iodine and iodine-containing compounds on thyroid function. Med Clin North Am 1985, 69:881-898.
12. Zhang N., Tong Y.J., Shan Z.Y., Teng W.P. Effect of chronic mild to moderate iodine excess on thyroid anti-oxidative ability of iodine deficiency and non-iodine deficiency Wistar rats. Zhonghua Yi Xue Za Zhi 2006, 86(18):1274-1278.
13. Laurberg P., Jørgensen T., Perrild H., Ovesen L., Knudsen N., Bulow Pedersen I., et al. The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives. Eur J Endocrinol 2006, 155(2):219-228.
14. El May M.V., Zekri S., Boubaker S., Ladgham A., El May A. Chronic iodine overload and apoptosis in cold nodules from endemic multinodular goiters. Arch Inst Pasteur Tunis 2005, 82(1-4):69-74.
15. Kidd P.M. Glutathione: systemic protectant against oxidative and free radical damage. Altern Med Rev 1997, 2(3):155-176.
16. Pastore A., Federici G., Bertini E., Piemonte F. Analysis of glutathione: implication in redox and detoxification. Clin Chim Acta 2003, 333(1):19-39.
17. Ashtiani Z.O., Hasheminasab S.M., Ayati M., Goulian B.S., Modarressi M.H. Are GSTM1, GSTT1 and CAG repeat length of androgen receptor gene polymorphisms associated with risk of prostate cancer in Iranian patients?. Pathol Oncol Res 2011, 17(2):269-275.
18. Vaziri N.D., Wang X., Oveisi F., Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 2000, 36(1):142-146.
19. Livingstone C., Davis J. Targeting therapeutics against glutathione depletion in diabetes and its complications. Br J Diab Vasc Dis 2007, 7(6):258-265.
20. Perricone C., De Carolis C., Perricone R. Glutathione: a key player in autoimmunity. Autoimmun Rev 2009, 8(8):697-701.
21. Higuchi Y. Glutathione depletion-induced chromosomal DNA fragmentation associated with apoptosis and necrosis. J Cell Mol Med 2004, 8(4):455-464.
22. Franco R., Cidlowski J.A. Apoptosis and glutathione: beyond an antioxidant. Cell Death Differ 2009, 16(10):1303-1314.
23. Droge W., Pottmeyer-Gerber C., Schmidt H., Nick S. Glutathione augments the activation of cytotoxic T lymphocytes in vivo. Immunobiology 1986, 172:151-156.
24. Perricone C., De Carolis C., Giacomelli R., Greco E., Cipriani P., Ballanti E., et al. Inhibition of the complement system by glutathione: molecular mechanisms and potential therapeutic implications. Int J Immunopathol Pharmacol 2011, 24(1):63-68.
25. Ghibelli L., Coppola S., Fanelli C., Rotilio G., Civitareale P., Scovassi A.I., et al. Glutathione depletion causes cytochrome c release even in the absence of cell commitment to apoptosis. FASEB J 1999, 13(14):2031-2036.
26. Gerenova J., Gadjeva V. Oxidative stress and antioxidant enzyme activities in patients with Hashimoto's thyroiditis. Comp Clin Pathol 2007, 16(4):259-264.
27. Lassoued S., Mseddi M., Mnif F., Abid M., Guermazi F., Masmoudi H., et al. A comparative study of the oxidative profile in Graves' disease, Hashimoto's thyroiditis, and papillary thyroid cancer. Biol Trace Elem Res 2010, 138(1-3):107-115.
28. Nanda N., Bobby Z., Hamide A. Oxidative stress in anti thyroiperoxidase antibody positive hypothyroid patient. Asian J Biochem 2012, 7(1):54-58.
29. Brunn J., Block U., Ruf G., Bos I., Kunze W.P., Scriba P.C. Volumetric analysis of thyroid lobes by real-time ultrasound. Dtsch Med Wochenschr 1981, 106:1338-1340.
30. Dunn J.T., Crutchfield H.E., Gutekunst R., Dunn A.D. Two simple methods for measuring iodine in urine. Thyroid 1993, 3:119-123.
31. Zhang W., Mnatsakanov A., Hower R., Cantor H., Wang Y. Urinary iodine assays and ionophore based potentiometric iodide sensors. Front Biosci 2005, 10:88-93.
32. Teitz F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: application to mammalian blood and other tissue. Anal Biochem 1969, 27:502-522.
33. Paglia D.E., Valentine W.N. Studies on quantitative and qualitative characterization of erythrocyte glutathione peroxidase as selenocystein. J Lab Clin Med 1967, 70:158-169.
34. Delides A., Spooner R.J., Goldberg D.M., Neal F.E. An optimized semi-automatic rate method for serum glutathione reductase activity and its application to patient with malignant disease. J Clin Pathol 1976, 29:73-77.
35. Committee of enzyme of Scandinavian Society for Clinical Chemistry and Clinical Physiology: recommended method for the determination of γ-GT in blood. Scand J Clin Lab Invest 1976, 36:119-125.
36. Alsayed A., Gad A., Abdel-Baset H., Abdel-Fattah A., Ahmed A., Azab A. Excessive urinary iodine is associated with autoimmune subclinical hypothyroidism among Egyptian women. Endocr J 2008, 55(3):601-605.
37. Dayan C.M., Daniels G.H. Chronic autoimmune thyroiditis. N Engl J Med 1996, 335(2):99-107.
38. Poncin S., Gérard A.C., Boucquey M., Senou M., Calderon P.B., Knoops B., et al. Oxidative stress in the thyroid gland: from harmlessness to hazard depending on the iodine content. Endocrinology 2008, 149(1):424-433.
39. Resch U., Helsel G., Tatzber F., Sinzinger H. Antioxidant status in thyroid dysfunction. Clin Chem Lab Med 2002, 40(11):1132-1134.
40. Gamaley I.A., Klyubin I.V. Roles of reactive oxygen species: signaling and regulation of cellular functions. Int Rev Cytol 1999, 188:203-255.
41. Joanta A.E., Filip A., Clichici S., Andrei S., Daicoviciu D. Iodide excess exerts oxidative stress in some target tissues of the thyroid hormones. Acta Physiol Hung 2006, 93(4):347-359.
42. Many M.C., Mestdagh C., Van Den Hove M.F., Denef J.F. In vitro study of acute toxic effects of high iodide doses in human thyroid follicles. Endocrinology 1992, 131(2):621-630.
43. Yan Z., Banerjee R. Redox remodeling as an immunoregulatory strategy. Biochemistry 2010, 49(6):1059-1066.
44. Ortona E., Margutti P., Matarrese P., Franconi F., Malorni W. Redox state, cell death and autoimmune diseases: a gender perspective. Autoimmun Rev 2008, 7(7):579-584.
45. Pasupathi P., Latha R. Free radical activity and antioxidant defense mechanisms in patients with hypothyroidism. Thyroid Sci 2008, 3:1-6.
46. Nanda N., Bobby Z., Hamide A. Oxidative stress and protein glycation in primary hypothyroidism. Male/female difference. Clin Exp Med 2008, 8:101-108.
47. Brigelius-Flohé R., Flohé L. Is there a role of glutathione peroxidases in signaling and differentiation?. Biofactors 2003, 17(1-4):93-102.
48. Chiu-Ugalde J., Wirth E.K., Klein M.O., Sapin R., Fradejas-Villar N., Renko K., et al. Thyroid function is maintained despite increased oxidative stress in mice lacking selenoprotein biosynthesis in thyroid epithelial cells. Antioxid Redox Signal 2012, 17:902-913.
49. Nakamura Y., Ohtaki S., Makino R., Tanaka T., Ishimura Y. Superoxide anion is the initial product in the hydrogen peroxide formation catalyzed by NADPH oxidase in porcine thyroid plasma membrane. J Biol Chem 1989, 264:4759-4761.
50. Dupuy C., Virion A., Ohayon R., Kaniewski J., Dème D., Pommier J. Mechanism of hydrogen peroxide formation catalyzed by NADPH oxidase in thyroid plasma membrane. J Biol Chem 1991, 266:3739-3743.
51. Demelash A., Kalsson J.-O., Nilsson M., Björkman U.S. Selenium has a protective role in caspase-3-dependent apoptosis induced by H2O2 in primary cultured pig thyrocytes. Eur J Endocrinol 2004, 150:841-849.